Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs
Condition(s):Pancreatic CancerLast Updated:November 23, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Pancreatic CancerLast Updated:November 23, 2020Unknown status
Condition(s):Lung CancerLast Updated:September 23, 2016Unknown status
Condition(s):Carcinoma, Hepatocellular; Neoplasm Circulating CellsLast Updated:November 14, 2013Unknown status
Condition(s):Prostate CancerLast Updated:August 20, 2020Terminated
Condition(s):Melanoma Stage IV; Sarcoma; Squamous Cell Carcinoma; Pancreatic Cancer Stage IV; Prostate Cancer; Breast Cancer Stage IVLast Updated:May 14, 2021Unknown status
Condition(s):Metastatic Colorectal CancerLast Updated:March 31, 2023Completed
Condition(s):Esophageal CancerLast Updated:March 8, 2024Completed
Condition(s):Head and Neck CancerLast Updated:August 8, 2018Completed
Condition(s):Bladder Cancer; Circulating Tumor CellsLast Updated:January 26, 2015Completed
Condition(s):Circulating Tumor Cells; Pancreatic Adenocarcinoma; Circulating Tumor DNA (KRAS); CA 19.9Last Updated:May 29, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.